A roundup of all the latest news on www.globaluniversityventuring.com for our subscribers.

Big deal: Oxford PV begins capturing series D Goldwind, Legal & General and Equinor have all taken part in a series D that achieved a $41m first close and boosted the Oxford spinout’s total equity and debt to more than $118m. Respirion inhales $14.2m Cystic fibrosis drug developer Respirion Pharmaceuticals has spun out from Telethon…

The rest of this content is only accessible to Global Venturing Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.